ERCP-Related Adverse Events in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis
Table 1
Definition of ERCP-related adverse events.
Cholangitis
Pancreatitis
Bleeding
Perforation
Adler (2016)
Not defined
Not defined
Not defined
Not defined
Bangarulingam (2009)
Requiring hospitalization for intravenous/intramuscular antibiotics for fever within 2 days of the procedure
Admission to hospital with abdominal pain and documentation of pancreatitis by the gastroenterologist
Hospitalization within 1 week of procedure with melena requiring transfusion or confirmation of bleeding on repeat endoscopy
Documentation of contrast extravasation during the procedure by the endoscopist, or evidence of bile leak on abdominal imaging after the procedure
Etzel (2008)
Not defined
Not defined
Not defined
Not defined
Von Seth (2015)
Defined at the discretion of the attending clinician in patients requiring hospitalization for intravenous antibiotics
Abdominal pain and elevation in amylase by at least three times more than 24 hours from the procedure, and requiring admission or prolongation of admission for at least 2 days
Confirmed evidence of bleeding requiring transfusion and/or endoscopic/surgical intervention
